COSYNTROPIN

COSYNTROPIN was reported 220 times

COSYNTROPIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CITROBACTER TEST POSITIVE 1 0.0152
1 CLOSTRIDIUM DIFFICILE SEPSIS 1 0.0089
2 BLOOD CATECHOLAMINES INCREASED 1 0.0080
3 CONGENITAL ANOMALY IN OFFSPRING 1 0.0076
4 LESION EXCISION 1 0.0070
5 FACTITIOUS DISORDER 1 0.0066
6 ADAMS-STOKES SYNDROME 1 0.0065
7 CUTANEOUS CALCIFICATION 1 0.0055
8 PSEUDOALDOSTERONISM 1 0.0051
9 CORTISOL ABNORMAL 1 0.0050
10 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
11 HYPERINSULINAEMIC HYPOGLYCAEMIA 1 0.0045
12 FOETAL GROWTH RESTRICTION 24 0.0039
13 VITAMIN B6 DECREASED 1 0.0039
14 HYPOGLYCAEMIA NEONATAL 6 0.0037
15 AGONAL RESPIRATION 1 0.0035
16 HYPEROSMOLAR STATE 1 0.0035
17 PRIMARY ADRENAL INSUFFICIENCY 1 0.0033
18 OESTRADIOL DECREASED 1 0.0031
19 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
20 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 2 0.0027
21 CORTISOL DECREASED 3 0.0026
22 GALLBLADDER PERFORATION 1 0.0026
23 VASCULAR INSUFFICIENCY 1 0.0026
24 ALLERGIC GRANULOMATOUS ANGIITIS 2 0.0024
25 PERIPHERAL SENSORIMOTOR NEUROPATHY 3 0.0024
26 GLUCOCORTICOID DEFICIENCY 1 0.0024
27 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
28 URTICARIAL VASCULITIS 1 0.0019
29 ADRENAL HAEMORRHAGE 1 0.0018
30 SJOGREN'S SYNDROME 1 0.0017
31 PALATAL DISORDER 1 0.0017
32 ANOXIC ENCEPHALOPATHY 1 0.0016
33 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
34 HYPERMAGNESAEMIA 1 0.0015
35 INJECTION SITE EXFOLIATION 1 0.0015
36 RENAL VEIN THROMBOSIS 1 0.0015
37 ANASTOMOTIC LEAK 1 0.0014
38 CUSHING'S SYNDROME 1 0.0014
39 ANTICONVULSANT DRUG LEVEL DECREASED 2 0.0014
40 ESCHAR 1 0.0014
41 CHOLANGITIS ACUTE 1 0.0013
42 DEBRIDEMENT 1 0.0013
43 ADENOMA BENIGN 1 0.0012
44 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
45 INTUSSUSCEPTION 1 0.0010
46 PARTNER STRESS 1 0.0010
47 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
48 BLOOD SODIUM ABNORMAL 1 0.0009
49 BLOODY DISCHARGE 1 0.0009
50 STREPTOCOCCAL SEPSIS 1 0.0008
51 ESCHERICHIA TEST POSITIVE 1 0.0008
52 BRONCHIAL HYPERREACTIVITY 1 0.0008
53 ADRENAL INSUFFICIENCY 10 0.0008
54 SUBCUTANEOUS HAEMATOMA 1 0.0008
55 ENDOCRINE DISORDER 1 0.0008
56 OBSTRUCTION GASTRIC 1 0.0008
57 TRANSITIONAL CELL CARCINOMA 1 0.0008
58 PROTEIN TOTAL ABNORMAL 1 0.0008
59 ACROCHORDON 1 0.0008
60 FANCONI SYNDROME 1 0.0007
61 BLOOD ELECTROLYTES DECREASED 1 0.0007
62 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
63 STRIDOR 2 0.0007
64 CONJUNCTIVITIS ALLERGIC 1 0.0007
65 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
66 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
67 NEURITIS 1 0.0006
68 VASOPLEGIA SYNDROME 1 0.0006
69 SEBORRHOEIC DERMATITIS 1 0.0006
70 DERMATITIS EXFOLIATIVE 3 0.0006
71 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
72 HYPOPITUITARISM 1 0.0006
73 ILEAL STENOSIS 1 0.0006
74 TETANY 1 0.0005
75 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
76 LOBAR PNEUMONIA 1 0.0005
77 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
78 MUSCLE HAEMORRHAGE 2 0.0005
79 HYPOPHYSITIS 1 0.0005
80 CHOLANGITIS SCLEROSING 1 0.0005
81 BODY TEMPERATURE FLUCTUATION 1 0.0005
82 HYPERPHOSPHATAEMIA 1 0.0005
83 PSEUDOMEMBRANOUS COLITIS 1 0.0004
84 METASTATIC MALIGNANT MELANOMA 1 0.0004
85 ISCHAEMIA 2 0.0004
86 ESCHERICHIA BACTERAEMIA 1 0.0004
87 HYPOGLYCAEMIA 20 0.0004
88 CANCER PAIN 1 0.0004
89 PROCTITIS 1 0.0004
90 RENAL TUBULAR DISORDER 1 0.0004
91 OESOPHAGEAL STENOSIS 1 0.0004
92 PHARYNGEAL DISORDER 1 0.0003
93 ESCHERICHIA SEPSIS 1 0.0003
94 ADENOVIRUS INFECTION 1 0.0003
95 HAEMOTHORAX 1 0.0003
96 SKIN WARM 2 0.0003
97 ATYPICAL PNEUMONIA 1 0.0003
98 THYROIDITIS 1 0.0003
99 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
100 BRAIN DEATH 1 0.0003
101 MULTIPLE-DRUG RESISTANCE 1 0.0003
102 BLOOD CREATININE DECREASED 1 0.0003
103 RESPIRATORY RATE DECREASED 1 0.0003
104 BILE DUCT STONE 1 0.0003
105 HYPERKALAEMIA 11 0.0003
106 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
107 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
108 INJECTION SITE INFECTION 1 0.0003
109 PEPTIC ULCER 1 0.0003
110 LEFT VENTRICULAR FAILURE 1 0.0003
111 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
112 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
113 HEPATIC NECROSIS 1 0.0003
114 TROPONIN INCREASED 2 0.0003
115 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
116 EPIGASTRIC DISCOMFORT 1 0.0003
117 CHOLECYSTITIS 3 0.0003
118 INTRACRANIAL ANEURYSM 1 0.0002
119 CYSTITIS HAEMORRHAGIC 1 0.0002
120 EOSINOPHIL COUNT INCREASED 2 0.0002
121 CARDIAC FAILURE CHRONIC 1 0.0002
122 ABDOMINAL ABSCESS 1 0.0002
123 ILEUS PARALYTIC 1 0.0002
124 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
125 LOCALISED OEDEMA 1 0.0002
126 NEPHROGENIC ANAEMIA 1 0.0002
127 INTERCEPTED MEDICATION ERROR 1 0.0002
128 HEPATIC STEATOSIS 4 0.0002
129 PULSE ABSENT 1 0.0002
130 SUBCUTANEOUS ABSCESS 1 0.0002
131 ATELECTASIS 2 0.0002
132 ENTEROCOCCAL INFECTION 1 0.0002
133 PHARYNGEAL SWELLING 2 0.0002
134 RENAL TUBULAR NECROSIS 2 0.0002
135 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
136 HYPERNATRAEMIA 1 0.0002
137 HYPERBILIRUBINAEMIA 2 0.0002
138 FAILURE TO THRIVE 1 0.0002
139 APLASTIC ANAEMIA 1 0.0002
140 SERUM FERRITIN INCREASED 1 0.0002
141 PHARYNGOLARYNGEAL PAIN 1 0.0002
142 HYDROCEPHALUS 1 0.0002
143 ACUTE PULMONARY OEDEMA 1 0.0002
144 ENTEROCOLITIS 1 0.0002
145 STRESS CARDIOMYOPATHY 1 0.0002
146 PRODUCT LABEL CONFUSION 1 0.0002
147 POLYNEUROPATHY 2 0.0002
148 INJECTION SITE VESICLES 1 0.0002
149 PRESYNCOPE 4 0.0002
150 CHOLANGITIS 1 0.0002
151 HYPOCALCAEMIA 3 0.0002
152 ANGINA UNSTABLE 1 0.0002
153 TENDON DISORDER 1 0.0002
154 BLOOD TESTOSTERONE DECREASED 1 0.0001
155 ENCEPHALITIS 1 0.0001
156 HAIR GROWTH ABNORMAL 1 0.0001
157 PULMONARY HYPERTENSION 3 0.0001
158 HYPOXIA 5 0.0001
159 NEUTROPENIC SEPSIS 1 0.0001
160 FLUID OVERLOAD 2 0.0001
161 HYPOPHOSPHATAEMIA 1 0.0001
162 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
163 ARTHROPOD BITE 1 0.0001
164 HAEMORRHAGE INTRACRANIAL 2 0.0001
165 HYDRONEPHROSIS 1 0.0001
166 ACIDOSIS 1 0.0001
167 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
168 PROCEDURAL COMPLICATION 1 0.0001
169 DEVICE RELATED INFECTION 2 0.0001
170 ATRIOVENTRICULAR BLOCK 1 0.0001
171 CONCUSSION 1 0.0001
172 APNOEA 1 0.0001
173 BLOOD ALBUMIN DECREASED 1 0.0001
174 RENAL CYST 1 0.0001
175 SUBSTANCE ABUSE 1 0.0001
176 POLYURIA 1 0.0001
177 ABNORMAL FAECES 1 0.0001
178 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
179 VITAMIN D DECREASED 1 0.0001
180 DRUG RESISTANCE 3 0.0001
181 PRODUCT CONTAINER ISSUE 1 0.0001
182 MULTI-ORGAN FAILURE 2 0.0001
183 PYELONEPHRITIS 1 0.0001
184 NEUROTOXICITY 2 0.0001
185 SPINAL OSTEOARTHRITIS 1 0.0001
186 TUMOUR LYSIS SYNDROME 1 0.0001
187 PRODUCT COMMUNICATION ISSUE 1 0.0001
188 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
189 RESPIRATORY RATE INCREASED 1 0.0001
190 WRONG DRUG ADMINISTERED 1 0.0001
191 RESPIRATORY DISTRESS 3 0.0001
192 INCREASED TENDENCY TO BRUISE 1 0.0001
193 NEPHROPATHY 1 0.0001
194 SPUTUM DISCOLOURED 1 0.0001
195 HYPERCHOLESTEROLAEMIA 1 0.0001
196 PARKINSONISM 1 0.0001
197 EMPHYSEMA 1 0.0001
198 HYPOTHERMIA 1 0.0001
199 SEPSIS 11 0.0001
200 SUBARACHNOID HAEMORRHAGE 1 0.0001
201 NEUTROPHIL COUNT INCREASED 1 0.0001
202 FULL BLOOD COUNT ABNORMAL 1 0.0001
203 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
204 HYPOTENSION 18 0.0001
205 PANCYTOPENIA 5 0.0001
206 MALNUTRITION 1 0.0001
207 PULMONARY OEDEMA 4 0.0001
208 HYPONATRAEMIA 5 0.0001
209 IMPAIRED DRIVING ABILITY 1 0.0001
210 SHOCK 2 0.0001
211 PERICARDIAL EFFUSION 2 0.0001
212 VASCULITIS 1 0.0001
213 SPINAL PAIN 1 0.0001
214 HYPERLIPIDAEMIA 1 0.0001
215 ENCEPHALOPATHY 2 0.0001
216 ILEUS 1 0.0001
217 SYNCOPE 8 0.0001
218 BRAIN OEDEMA 1 0.0001
219 ANAPHYLACTIC SHOCK 2 0.0001
220 IMMUNE SYSTEM DISORDER 1 0.0001
221 PULMONARY CONGESTION 1 0.0001
222 SINUS CONGESTION 1 0.0001
223 TACHYPNOEA 1 0.0001
224 PALLOR 2 0.0001
225 GINGIVAL BLEEDING 1 0.0001
226 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
227 MENTAL STATUS CHANGES 2 0.0001
228 HYPOMAGNESAEMIA 1 0.0001
229 HUNGER 1 0.0001
230 BLOOD TEST ABNORMAL 1 0.0001
231 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
232 RENAL FAILURE ACUTE 3 0.0001
233 SINUS TACHYCARDIA 1 0.0001
234 PARALYSIS 1 0.0001
235 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
236 HYPERTHYROIDISM 1 0.0001
237 SEPTIC SHOCK 3 0.0001
238 LIVER FUNCTION TEST ABNORMAL 2 0.0001
239 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
240 PULMONARY MASS 1 0.0001
241 ECONOMIC PROBLEM 1 0.0001
242 PHARYNGEAL OEDEMA 1 0.0001
243 THYROID DISORDER 1 0.0001
244 BASAL CELL CARCINOMA 1 0.0001
245 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
246 ULCER 1 0.0001
247 CYSTITIS 2 0.0001
248 SCIATICA 1 0.0001
249 HYPOTHYROIDISM 2 0.0001
250 MUSCLE TIGHTNESS 1 0.0001
251 BLOOD POTASSIUM INCREASED 1 0.0001
252 BACK DISORDER 1 0.0001
253 BLOOD CREATININE INCREASED 4 0.0001
254 STAPHYLOCOCCAL INFECTION 2 0.0001
255 FUNGAL INFECTION 2 0.0001
256 RENAL IMPAIRMENT 5 0.0001
257 CIRCULATORY COLLAPSE 1 0.0001
258 PARANOIA 1 0.0001
259 DELIRIUM 2 0.0001
260 LOCAL SWELLING 1 0.0001
261 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
262 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
263 GALLBLADDER DISORDER 1 0.0001
264 BONE DISORDER 1 0.0001
265 END STAGE RENAL DISEASE 1 0.0001
266 CONJUNCTIVITIS 1 0.0001
267 THROMBOCYTOPENIA 6 0.0001
268 OXYGEN SATURATION DECREASED 3 0.0001
269 MUSCULOSKELETAL DISORDER 1 0.0001
270 PULMONARY FIBROSIS 1 0.0001
271 CHOLESTASIS 1 0.0001
272 POST PROCEDURAL COMPLICATION 1 0.0001
273 ACUTE RESPIRATORY FAILURE 1 0.0001
274 DYSTONIA 1 0.0001
275 MENORRHAGIA 1 0.0001
276 HAEMATOCRIT DECREASED 1 0.0001
277 CYTOKINE RELEASE SYNDROME 1 0.0000
278 CARDIAC FAILURE 4 0.0000
279 PRODUCT ADMINISTRATION ERROR 1 0.0000
280 DYSKINESIA 2 0.0000
281 NEUTROPHIL COUNT DECREASED 2 0.0000
282 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
283 PRODUCT PREPARATION ERROR 1 0.0000
284 RIB FRACTURE 1 0.0000
285 DERMATITIS 1 0.0000
286 POOR QUALITY SLEEP 1 0.0000
287 RHINORRHOEA 3 0.0000
288 FAECES DISCOLOURED 1 0.0000
289 FEBRILE NEUTROPENIA 3 0.0000
290 TACHYCARDIA 4 0.0000
291 STEVENS-JOHNSON SYNDROME 1 0.0000
292 TRANSAMINASES INCREASED 1 0.0000
293 RASH PAPULAR 1 0.0000
294 PRODUCT AVAILABILITY ISSUE 1 0.0000
295 BLOOD PRESSURE FLUCTUATION 1 0.0000
296 RESPIRATORY FAILURE 3 0.0000
297 ATRIAL FIBRILLATION 4 0.0000
298 PNEUMONIA 13 0.0000
299 LEUKOPENIA 2 0.0000
300 HYPOPHAGIA 1 0.0000
301 CHEST DISCOMFORT 4 0.0000
302 UNRESPONSIVE TO STIMULI 1 0.0000
303 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
304 JOINT STIFFNESS 1 0.0000
305 ANHEDONIA 1 0.0000
306 GASTRITIS 1 0.0000
307 RENAL FAILURE 5 0.0000
308 EAR INFECTION 1 0.0000
309 MENSTRUATION IRREGULAR 1 0.0000
310 DISTURBANCE IN ATTENTION 2 0.0000
311 PNEUMONITIS 1 0.0000
312 TREMOR 6 0.0000
313 MEDICATION ERROR 2 0.0000
314 FEELING COLD 1 0.0000
315 WOUND 1 0.0000
316 BALANCE DISORDER 3 0.0000
317 PALPITATIONS 4 0.0000
318 CHILLS 4 0.0000
319 ACUTE MYOCARDIAL INFARCTION 1 0.0000
320 WHEEZING 2 0.0000
321 HYPERTENSION 7 0.0000
322 PLEURAL EFFUSION 2 0.0000
323 EPILEPSY 1 0.0000
324 DRUG-INDUCED LIVER INJURY 1 0.0000
325 METABOLIC ACIDOSIS 1 0.0000
326 DEEP VEIN THROMBOSIS 2 0.0000
327 CHOLELITHIASIS 1 0.0000
328 IMPAIRED HEALING 1 0.0000
329 HEART RATE INCREASED 3 0.0000
330 INFUSION RELATED REACTION 2 0.0000
331 BLOOD PRESSURE DECREASED 2 0.0000
332 EXPIRED PRODUCT ADMINISTERED 1 0.0000
333 DEHYDRATION 4 0.0000
334 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
335 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
336 PANIC ATTACK 1 0.0000
337 DYSURIA 1 0.0000
338 HYPOAESTHESIA 4 0.0000
339 PRODUCT USE ISSUE 5 0.0000
340 DYSARTHRIA 1 0.0000
341 HOT FLUSH 2 0.0000
342 INTESTINAL OBSTRUCTION 1 0.0000
343 CHRONIC KIDNEY DISEASE 2 0.0000
344 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
345 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
346 ABORTION SPONTANEOUS 1 0.0000
347 CARDIAC FAILURE CONGESTIVE 2 0.0000
348 PSORIATIC ARTHROPATHY 1 0.0000
349 OEDEMA PERIPHERAL 3 0.0000
350 LUNG NEOPLASM MALIGNANT 1 0.0000
351 CARDIAC ARREST 2 0.0000
352 RHABDOMYOLYSIS 1 0.0000
353 CARDIO-RESPIRATORY ARREST 1 0.0000
354 SKIN EXFOLIATION 2 0.0000
355 OSTEOARTHRITIS 1 0.0000
356 URINARY TRACT INFECTION 4 0.0000
357 DYSPNOEA 13 0.0000
358 RASH 10 0.0000
359 PRODUCT STORAGE ERROR 2 0.0000
360 NEUTROPENIA 3 0.0000
361 NEPHROLITHIASIS 1 0.0000
362 SKIN DISCOLOURATION 1 0.0000
363 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
364 CHEST PAIN 4 0.0000
365 HYPERSENSITIVITY 4 0.0000
366 BLOOD CHOLESTEROL INCREASED 1 0.0000
367 ANXIETY 6 0.0000
368 PRODUCTIVE COUGH 1 0.0000
369 BLOOD GLUCOSE DECREASED 1 0.0000
370 LUNG DISORDER 1 0.0000
371 ACUTE KIDNEY INJURY 3 0.0000
372 ILLNESS 2 0.0000
373 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
374 ABDOMINAL DISTENSION 2 0.0000
375 SPEECH DISORDER 1 0.0000
376 PANCREATITIS 1 0.0000
377 DRUG INTERACTION 3 0.0000
378 BRADYCARDIA 1 0.0000
379 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
380 ANAPHYLACTIC REACTION 1 0.0000
381 FALL 6 0.0000
382 URTICARIA 3 0.0000
383 LETHARGY 1 0.0000
384 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
385 ABDOMINAL PAIN 4 0.0000
386 COVID-19 3 0.0000
387 DYSPHONIA 1 0.0000
388 BONE PAIN 1 0.0000
389 NASAL CONGESTION 1 0.0000
390 PAIN IN EXTREMITY 5 0.0000
391 STOMATITIS 1 0.0000
392 VERTIGO 1 0.0000
393 FEELING HOT 1 0.0000
394 EXPOSURE DURING PREGNANCY 1 0.0000
395 DIZZINESS 8 0.0000
396 ANAEMIA 3 0.0000
397 GAIT DISTURBANCE 3 0.0000
398 NAUSEA 12 0.0000
399 SOMNOLENCE 3 0.0000
400 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
401 VISION BLURRED 2 0.0000
402 MEMORY IMPAIRMENT 2 0.0000
403 COUGH 4 0.0000
404 INJURY 1 0.0000
405 SLEEP DISORDER 1 0.0000
406 CONSTIPATION 3 0.0000
407 BRONCHITIS 1 0.0000
408 WEIGHT INCREASED 3 0.0000
409 EPISTAXIS 1 0.0000
410 ASTHENIA 5 0.0000
411 DIABETES MELLITUS 1 0.0000
412 BLOOD PRESSURE INCREASED 2 0.0000
413 INJECTION SITE SWELLING 1 0.0000
414 PERIPHERAL SWELLING 2 0.0000
415 BACK PAIN 3 0.0000
416 ARTHRITIS 1 0.0000
417 INJECTION SITE BRUISING 1 0.0000
418 FEELING ABNORMAL 3 0.0000
419 THROMBOSIS 1 0.0000
420 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
421 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
422 TREATMENT FAILURE 1 0.0000
423 MYOCARDIAL INFARCTION 2 0.0000
424 INTENTIONAL PRODUCT MISUSE 1 0.0000
425 MUSCULOSKELETAL STIFFNESS 1 0.0000
426 HEADACHE 7 0.0000
427 NO ADVERSE EVENT 2 0.0000
428 NASOPHARYNGITIS 2 0.0000
429 WEIGHT DECREASED 3 0.0000
430 SWELLING 1 0.0000
431 VOMITING 5 0.0000
432 DYSPHAGIA 1 0.0000
433 PULMONARY EMBOLISM 1 0.0000
434 NEUROPATHY PERIPHERAL 1 0.0000
435 CONTUSION 1 0.0000
436 ALOPECIA 2 0.0000
437 FLUSHING 1 0.0000
438 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
439 HAEMOGLOBIN DECREASED 1 0.0000
440 ARTHRALGIA 4 0.0000
441 PLATELET COUNT DECREASED 1 0.0000
442 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
443 OFF LABEL USE 8 0.0000
444 INFLUENZA 1 0.0000
445 SEIZURE 1 0.0000
446 DECREASED APPETITE 2 0.0000
447 EMOTIONAL DISTRESS 1 0.0000
448 VISUAL IMPAIRMENT 1 0.0000
449 INJECTION SITE ERYTHEMA 1 0.0000
450 DRY SKIN 1 0.0000
451 CONDITION AGGRAVATED 2 0.0000
452 INJECTION SITE PAIN 2 0.0000
453 PAIN 4 0.0000
454 FATIGUE 5 0.0000
455 PARAESTHESIA 1 0.0000
456 DIARRHOEA 4 0.0000
457 CONFUSIONAL STATE 1 0.0000
458 ABDOMINAL DISCOMFORT 1 0.0000
459 CEREBROVASCULAR ACCIDENT 1 0.0000
460 PYREXIA 2 0.0000
461 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
462 BLOOD GLUCOSE INCREASED 1 0.0000
463 PRURITUS 2 0.0000
464 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
465 ERYTHEMA 1 0.0000
466 MALAISE 2 0.0000
467 DRUG INEFFECTIVE 6 0.0000
468 DEPRESSION 1 0.0000
469 INCORRECT DOSE ADMINISTERED 1 0.0000
470 INSOMNIA 1 0.0000
471 DEATH 3 0.0000